EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Mechanistic insight of interleukin‐9 induced osteoclastogenesis

Sushmita Chakraborty iD, Jakob Schneider, Dipendra Kumar Mitra, Katharina F Kubatzky iD

Immunology · 2023-07 · 169 (3) · 309-322

DOI: 10.1111/imm.13630 ↗

At a glance

Journal article in Immunology, published online on 2023-02-15. Written by Sushmita Chakraborty and 3 co-authors. Institution: Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany. Major MEDLINE topics: Osteogenesis, Arthritis, Rheumatoid. Cited 11 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, DBT-Wellcome Trust India Alliance, The Wellcome Trust DBT India Alliance.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Interleukin (IL)‐9 is an emerging player in the pathogenesis of various chronic inflammatory diseases including bone disorders like rheumatoid arthritis (RA) and psoriatic arthritis. Recently, IL‐9 was shown to enhance the osteoclast formation and their function in RA. However, the mechanisms by which IL‐9 influences osteoclastogenesis are not known. Therefore, in this study we aimed to unravel the direct and indirect ways by which IL‐9 can influence osteoclast formation. We used mouse bone marrow precursor cells for checking the effect of IL‐9 on osteoclast differentiation and its function. Next, IL‐9 induced signalling pathway were checked in the process of osteoclastogenesis. T cells play an important role in enhancing osteoclastogenesis in inflammatory conditions. We used splenic T cells to understand the impact of IL‐9 on the functions of T effector (Teff) and regulatory T (Treg) cells. Furthermore, the effect of IL‐9 mediated modulation of the T cell response on osteoclasts was checked using a coculture model of T cells with osteoclast precursors. We showed that IL‐9 enhanced osteoclast formation and its function. We found that IL‐9 activates STAT3, P38 MAPK, ERK1/2, NFκB and we hypothesize that it mediates the effect on osteoclastogenesis by accelerating mitochondrial biogenesis. Additionally, IL‐9 was observed to facilitate the functions of pro‐osteoclastogenic IL‐17 producing T cells, but inhibits the function of anti‐osteoclastogenic Treg cells. Our observations suggest that IL‐9 can influence osteoclastogenesis directly by modulating the signalling cascade in the precursor cells; indirectly by enhancing IL‐17 producing T cells and by reducing the functions of Treg cells.

Subjects

MeSH terms (MEDLINE)

OsteogenesisArthritis, RheumatoidMiceAnimalsInterleukin-17Interleukin-9OsteoclastsSignal TransductionRANK LigandCell DifferentiationCells, Cultured

Author keywords

effector T cellsinterleukin-9osteoclastregulatory T cellssignal transduction

Substances

Interleukin-17Interleukin-9RANK Ligand

Authors and institutions

  • Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany.
  • Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.

ORCID profiles: Sushmita Chakraborty, Katharina F Kubatzky

Funding

  • Wellcome Trust
  • DBT-Wellcome Trust India Alliance
  • The Wellcome Trust DBT India Alliance

Cite

APA

Chakraborty, S., Schneider, J., Mitra, D. K., & Kubatzky, K. F. (2023). Mechanistic insight of interleukin‐9 induced osteoclastogenesis. Immunology, 169(3), 309-322. https://doi.org/10.1111/imm.13630

Vancouver

Chakraborty S, Schneider J, Mitra DK, Kubatzky KF. Mechanistic insight of interleukin‐9 induced osteoclastogenesis. Immunology. 2023;169(3):309-322. doi:10.1111/imm.13630

BibTeX
@article{Chakraborty2023,
  author = {Chakraborty, Sushmita and Schneider, Jakob and Mitra, Dipendra Kumar and Kubatzky, Katharina F},
  title = {Mechanistic insight of interleukin‐9 induced osteoclastogenesis},
  journal = {Immunology},
  year = {2023},
  volume = {169},
  number = {3},
  pages = {309--322},
  doi = {10.1111/imm.13630}
}
Start for free →